Physician profile
Gregory Lachaud
NPI 1265895197
$4,366.23
in general payments reported to CMS, 2019-2025
12 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $187 · 2023: $1,561 · 2024: $2,344 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,310 · Food and Beverage: $1,869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,310.32 |
| Food and Beverage | $1,868.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,084.44 | 2023-2024 | Mako, Insignia, Triathlon |
| Acumed LLC | $1,073.94 | 2023 | Acumed, Innate Implant |
| Arthrex, INC. | $466.35 | 2024 | |
| Onkos Surgical, INC. | $460.08 | 2022-2024 | Eleos Limb Salvage System |
| Medtronic, INC. | $329.00 | 2024-2025 | Aquamantys(Tm), Osteocool Rf Ablation System |
| Acera Surgical, INC. | $294.95 | 2023-2024 | Restrata Wound Matrix |
| Checkpoint Surgical, INC | $169.12 | 2023 | Checkpoint Stimulators |
| United Orthopedics LLC | $150.95 | 2024 | |
| Davol INC. | $145.66 | 2024 | Arista Ah Flexitip |
| Illuminoss Medical, INC. | $104.50 | 2025 | Photodynamic Bone Stabilization Procedure Pack |
| Heron Therapeutics, INC. | $53.00 | 2023 | Zynrelef |
| Smith+Nephew, INC. | $34.24 | 2023 | Grafix Xc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Lachaud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.